Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Allysine)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003521 AN005782 Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii Bacterial cells Acinetobacter baumannii Bacterial infection Monash University LC-MS
ST003521 AN005783 Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii Bacterial cells Acinetobacter baumannii Bacterial infection Monash University LC-MS
ST003144 AN005159 On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity Blood Plasmodium falciparum Malaria Monash University LC-MS
ST003089 AN005052 Metabolome changes in embryonic CSF (Part 11) CSF Mouse Autism Boston Children's Hospital, Harvard Medical School LC-MS
ST003088 AN005050 Metabolome changes in embryonic CSF (Part 10) Blood Mouse Autism Boston Children's Hospital, Harvard Medical School LC-MS
ST003088 AN005050 Metabolome changes in embryonic CSF (Part 10) CSF Mouse Autism Boston Children's Hospital, Harvard Medical School LC-MS
ST003088 AN005050 Metabolome changes in embryonic CSF (Part 10) Liver Mouse Autism Boston Children's Hospital, Harvard Medical School LC-MS
ST003087 AN005048 Metabolome changes in embryonic CSF (Part 9) CSF Mouse Autism Boston Children's Hospital, Harvard Medical School LC-MS
ST003086 AN005046 Metabolome changes in embryonic CSF (Part 8) CSF Mouse Autism Boston Children's Hospital, Harvard Medical School LC-MS
ST003085 AN005044 Metabolome changes in embryonic CSF (Part 7) CSF Mouse Autism Boston Children's Hospital, Harvard Medical School LC-MS
ST003036 AN004977 Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 Bacterial cells Pseudomonas aeruginosa Bacterial infection Monash Institute of Pharmaceutical Sciences LC-MS
ST003028 AN004964 Chronic stress dampens Lactobacillus johnsonii-mediated tumor suppression to enhance colorectal cancer progression Colon Mouse Cancer China Pharmaceutical University LC-MS
ST003002 AN004930 The role of gut microbiota in muscle mitochondria function, colon health, and sarcopenia: from clinical to bench (2) Feces Human Sarcopenia Chinese University of Hong Kong GC-MS/LC-MS
ST002998 AN004925 The role of gut microbiota in muscle mitochondria function, colon health, and sarcopenia: from clinical to bench Bacterial cells Lacticaseibacillus rhamnosus and Faecalibacterium prausnitzii Sarcopenia Chinese University of Hong Kong GC-MS/LC-MS
ST002792 AN004542 Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002787 AN004535 Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome Feces Human Cancer Wuhan University of Science and Technology LC-MS
ST002761 AN004487 Metabolic responses of normal rat kidneys to a high salt intake (Urine) Urine Rat Medical College of Wisconsin LC-MS
ST002698 AN004372 Systemic host inflammation induces stage-specific transcriptomic modification and slower maturation in malaria parasites Infected Red Blood Cells Plasmodium berghei Malaria Peter Doherty Institute for Infection and Immunity LC-MS
ST002104 AN003439 Chemoresistant Cancer Cell Lines are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling Perturbations Cultured cells Human Cancer Future Industries Institute LC-MS
ST002066 AN003365 Glutaminase inhibition impairs CD8 T cell activation in STK11/Lkb1 deficient lung cancer Lung Mouse Cancer Walter and Eliza Hall Institute of Medical Research LC-MS
ST002010 AN003276 Chemoresistant Ovarian Cancer Global Metabolomics Cultured cells Human Cancer University of South Australia LC-MS
ST001680 AN002738 Metabolome of NAFLD in high fat diet mouse model Liver Mouse Fatty liver disease Weill Cornell Medicine LC-MS
ST000549 AN000838 Investigating large scale metabolomics in mice serum lacking insulin receptors and IGF-1 receptors Blood Mouse Diabetes Mayo Clinic LC-MS
ST000539 AN000819 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) Cells Human Monash University LC-MS
ST000422 AN000668 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic LC-MS
ST000421 AN000664 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic LC-MS
ST000403 AN000643 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes Cells Human Monash Institute of Pharmaceutical Sciences LC-MS
ST000148 AN000235 A549 13C-labeled Cell Study Epithelial cells Human Cancer University of Kentucky LC-MS
ST000142 AN000225 H1299 13C-labeled Cell Study Lung Human Cancer University of Kentucky LC-MS
ST000047 AN000081 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic LC-MS
ST000040 AN000060 Heatshock response of C. elegans using IROA (I) Worms C. elegans University of Florida LC-MS
ST000040 AN000061 Heatshock response of C. elegans using IROA (I) Worms C. elegans University of Florida LC-MS
  logo